Skip to content

Clinical trials

Central Nervous System Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Poland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20144
20161
20171
20182
20191
20203
20211
20223
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting3
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca3
Auspex Pharmaceuticals, Inc.3
Alkahest, Inc.1
Amzell1
Bial R&D Investments, S.A.1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Guerbet1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases22
Nervous System Diseases18
Brain Diseases15
Neurodegenerative Diseases13
Movement Disorders10
Mental Disorders9
Dementia8
Alzheimer Disease7
Neurocognitive Disorders7
Tauopathies7

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.